Merck’s drug VIOXX faced its first litigation hurdle this week and lost big.
VIOXX is a painkiller prescribed for osteoarthritis. After its released as a painkiller, Merck tested the efficacy of VIOXX in preventing recurrence of colorectal polyps in patients with a history of colorectal adenomas. During that trial it was determined that VIOXX presented a greater risk for cardiovascular events after prolonged use. At that point Merck voluntarily withdrew the drug from the market.
Yesterday a Texas jury awarded the widow of Robert C Ernst, a Vioxx patient, $253 million. This was not a verdict Merck expected. Apparently Merck reserved millions of dollars to pay lawyers to defend the lawsuits against it, but reserved nothing to pay for losses. The adverse verdict also calls into question Merck’s decision to fend off a class action and try every case.
The Merck verdict once again raises the issue of tort reform.
I have mixed feelings about tort reform. On one hand I think juries can run out of control, although decreasingly so over the eighteen years I’ve been practicing law. On the other hand, I’m a fan of Learned Hand. Hand, a great Judge, believed that the assessment of risk, was best done by the marketplace: A company creates a bad product, people sue, the company makes changes. The market, left alone will be forced into the best decisions (or they will be sued out of existence.) There is nothing like a quarter of a billion dollar verdict to signal to a company that it is doing something wrong.
The second problem I have with tort reform is that it transfers the cost of injury away from the liable party to the taxpayer. If you cap the damages of a quadriplegic at $100,000, the responsible party is paying for about a teaspoonful of his life time care. The rest of the burden falls on you and I.
The third problem I have with tort reform is Bob.
You know Bob. He’s the guy who appears on your TV 5 times a day to preen about his natural male enhancement solution. I’m no prude but Bob bugs me.
Bob symbolizes a larger issue: Every time I see Bob I can’t help but wonder why drug companies are advertising prescription drugs on TV. If a drug requires a prescription, shouldn’t a doctor be the one to determine whether the medication is appropriate? And if so, why do I have to listen to dozens of Bob’s peddling dozens of drugs that only my doctor can prescribe? I can answer that question. Merck et.al. is hoping I will run to my doc, and demand some pill that suddenly will make some ache or pain go away.
I have neither osteoarthritis or heart disease (knock on wood) but I’ve known about Vioxx for longer than I care to remember. I know about it, because it was relentlessly advertised on TV until the day it was pulled. Merck’s advertising budget for VIOXX was $160.8 million.
That’s $160.8 million that could have been used to lower the cost of the drug, or speed up the research to determine it was hazardous, or pay part of the verdict in the Ernst case. That’s a solution that I suspect Judge Hand would have approved.